Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Glioma 2Recurrence 1Neoplasm Recurrence, Local 1Liver Neoplasms 1Glioblastoma 1Diffuse Intrinsic Pontine Glioma 1Childhood Brain Neoplasm 1Central Nervous System Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1Brain Neoplasms 1Adult Brain Glioblastoma 1

Interventions

Sorafenib 42Bevacizumab 16Oxaliplatin 13Radiosurgery 10Gemcitabine 10Doxorubicin 10Capecitabine 10Leucovorin 9Hepatectomy 9Fluorouracil 9Cisplatin 9Radiofrequency Ablation 8Nivolumab 8pembrolizumab 7Drug Therapy 7Carboplatin 7Irinotecan 6Cryosurgery 6Talaporfin 5Mitomycin 5Everolimus 5Erlotinib Hydrochloride 5Electroporation 5spartalizumab 4Sunitinib 4Melphalan 4Ipilimumab 4Epirubicin 4Embolization, Therapeutic 4regorafenib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Liver Neoplasms × Gadolinium × Clear all
NCT01895673 2016-12-15

PET-MRI After Radiofrequency Ablation (RFA) or Microwave Ablation (MWA)

Amsterdam UMC, location VUmc

Completed
20 enrolled
Gastrointestinal

Liver Neoplasms, Neoplasm Recurrence, Local

Data powered by HemOnc (CC BY 4.0) Colophon âš¡